ProfileGDS5822 / ILMN_1252548
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 1% 21% 1% 22% 32% 11% 8% 3% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15.11
GSM1276600PDAC Late Ablation Control 21521
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 14.81
GSM1276603PDAC Late Ablation 212.722
GSM1276604PDAC Late Ablation 316.332
GSM1303940PDAC Late Ablation_anti-CTLA4 19.911
GSM1303941PDAC Late Ablation_anti-CTLA4 26.18
GSM1303942PDAC Late Ablation_anti-CTLA4 32.93